AN UPDATE OF 2 RANDOMIZED TRIALS IN PREVIOUSLY UNTREATED MULTIPLE-MYELOMA COMPARING MELPHALAN AND PREDNISONE VERSUS 3-DRUG AND 5-DRUG COMBINATIONS - AN ARGENTINE GROUP FOR THE TREATMENT OF ACUTE-LEUKEMIA STUDY

被引：39
|
作者：
PAVLOVSKY, S [1 ]
CORRADO, C [1 ]
SANTARELLI, MT [1 ]
SASLAVSKY, J [1 ]
CAVAGNARO, F [1 ]
PALAU, M [1 ]
PINTO, MD [1 ]
HUBERMAN, A [1 ]
LEIN, JM [1 ]
机构：
[1] GRP ARGENTINO TRATAMIENTO LEUCEMIA AGUDA, BUENOS AIRES, ARGENTINA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1988年 / 6卷 / 05期
关键词：
D O I：
10.1200/JCO.1988.6.5.769
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：769 / 775
页数：7
相关论文
共 11 条
  • [1] TREATMENT OF MULTIPLE-MYELOMA WITH AN INTENSIVE 5-DRUG COMBINATION OR INTERMITTENT MELPHALAN AND PREDNISONE - A RANDOMIZED MULTICENTER TRIAL
    PALVA, IP
    AHRENBERG, P
    ALAHARJA, K
    ALMQVIST, A
    APAJALAHTI, J
    HALLMAN, H
    HANNINEN, A
    ILVONEN, M
    ISOMAA, B
    JARVENPAA, E
    JARVENTIE, G
    KILPI, H
    KOISTINEN, S
    KORPI, E
    KOIVUNEN, E
    KATKA, K
    LAHTINEN, R
    LAITINEN, A
    LEHTINEN, M
    MAKELA, H
    NYLANDEN, P
    OIVANEN, T
    PELLINIEMI, TT
    PULLI, T
    RAJAMAKI, A
    ROSENGARD, S
    TIMONEN, T
    WARIS, E
    WASASTJERNA, C
    VILPO, J
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 1987, 38 (01) : 50 - 54
  • [2] TREATMENT OF MULTIPLE-MYELOMA - AN ARGENTINE GROUP FOR THE TREATMENT OF ACUTE-LEUKEMIA STUDY
    DHINGRA, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (11) : 1784 - 1785
  • [3] TREATMENT OF MULTIPLE-MYELOMA - AN ARGENTINE GROUP FOR THE TREATMENT OF ACUTE-LEUKEMIA STUDY - REPLY
    PAVLOVSKY, S
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (11) : 1785 - 1785
  • [4] PHASE-III STUDY OF INTERMITTENT 5-DRUG REGIMEN (VBCMP) VERSUS INTERMITTENT 3-DRUG REGIMEN (VMP) VERSUS INTERMITTENT MELPHALAN AND PREDNISONE (MP) IN MYELOMATOSIS
    HANSEN, OP
    CLAUSEN, NAT
    DRIVSHOLM, A
    LAURSEN, B
    [J]. SCANDINAVIAN JOURNAL OF HAEMATOLOGY, 1985, 35 (05): : 518 - 524
  • [5] ORAL VERSUS INTRAVENOUS MELPHALAN AND PREDNISONE TREATMENT IN MULTIPLE-MYELOMA STAGE-II - A RANDOMIZED STUDY FROM THE MYELOMA GROUP OF CENTRAL SWEDEN
    OSTERBORG, A
    AHRE, A
    BJORKHOLM, M
    BJOREMAN, M
    BRENNING, G
    GAHRTON, G
    GRIMFORS, G
    GYLLENHAMMAR, H
    HAST, R
    JOHANSSON, B
    JULIUSSON, G
    JARNMARK, M
    KILLANDER, A
    KIMBY, E
    LERNER, R
    NILSSON, B
    PAUL, C
    SIMONSSON, B
    STALFELT, AM
    SMEDMYR, B
    SVEDMYR, E
    UDEN, AM
    WADMAN, B
    OSBY, E
    MELLSTEDT, H
    [J]. ACTA ONCOLOGICA, 1990, 29 (06) : 727 - 731
  • [6] NATURAL INTERFERON-ALPHA IN COMBINATION WITH MELPHALAN PREDNISONE VERSUS MELPHALAN PREDNISONE IN THE TREATMENT OF MULTIPLE-MYELOMA STAGE-II AND STAGE-III - A RANDOMIZED STUDY FROM THE MYELOMA GROUP OF CENTRAL SWEDEN
    OSTERBORG, A
    BJORKHOLM, M
    BJOREMAN, M
    BRENNING, G
    CARLSON, K
    CELSING, F
    GAHRTON, G
    GRIMFORS, G
    GYLLENHAMMAR, H
    HAST, R
    JOHANSSON, B
    JULIUSSON, G
    JARNMARK, M
    KIMBY, E
    LERNER, R
    LINDER, O
    MERK, K
    NILSSON, B
    OHRLING, M
    PAUL, C
    SIMONSSON, B
    SMEDMYR, B
    SVEDMYR, E
    STALFELT, AM
    STRANDER, H
    UDEN, AM
    OSBY, E
    MELLSTEDT, H
    [J]. BLOOD, 1993, 81 (06) : 1428 - 1434
  • [7] RANDOMIZED, OPEN-LABEL, PHASE 2 STUDY OF SILTUXIMAB (AN ANTI-IL-6 MAB) AND BORTEZOMIB-MELPHALAN-PREDNISONE VERSUS BORTEZOMIB-MELPHALAN-PREDNISONE IN PATIENTS WITH PREVIOUSLY UNTREATED MULTIPLE MYELOMA
    San Miguel, J.
    Blade, J.
    Samoilova, O.
    Shpilberg, O.
    Grosicki, S.
    Maloisel, F.
    Min, C.
    Zarzuela, M.
    Robak, T.
    Khuageva, N.
    Prasad, S.
    Goh, Y.
    Laubach, J.
    Spencer, A.
    Mateos, M.
    Palumbo, A.
    van de Velde, H.
    Uhlar, C.
    Qin, X.
    Xie, H.
    Orlowski, R.
    [J]. HAEMATOLOGICA, 2013, 98 : 97 - 97
  • [8] A RANDOMIZED CLINICAL-TRIAL COMPARING MELPHALAN PREDNISONE WITH OR WITHOUT INTERFERON ALFA-2B IN NEWLY DIAGNOSED PATIENTS WITH MULTIPLE-MYELOMA - A CANCER AND LEUKEMIA GROUP-B STUDY
    COOPER, MR
    DEAR, K
    MCINTYRE, OR
    OZER, H
    ELLERTON, J
    CANELLOS, G
    BERNHARDT, B
    DUGGAN, D
    FARAGHER, D
    SCHIFFER, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (01) : 155 - 160
  • [9] A RANDOMIZED TRIAL OF POSTOPERATIVE 5-VERSUS 3-DRUG CHEMOTHERAPY AFTER MASTECTOMY - A CANCER AND LEUKEMIA GROUP-B (CALGB) STUDY
    WEISS, RB
    TORMEY, DC
    HOLLAND, F
    WEINBERG, VE
    LESNICK, G
    PERLOFF, M
    FALKSON, G
    GLIDEWELL, OJ
    [J]. RECENT RESULTS IN CANCER RESEARCH, 1982, 80 : 170 - 176
  • [10] MULTIPLE-MYELOMA IN CENTRAL AND NORTHERN NORWAY 1981-1982 - A FOLLOW-UP-STUDY OF A RANDOMIZED CLINICAL-TRIAL OF 5-DRUG COMBINATION THERAPY VERSUS STANDARD THERAPY
    KILDAHLANDERSEN, O
    BJARK, P
    BONDEVIK, A
    BULL, O
    BURGESS, G
    DEHLI, O
    HOEL, S
    JAEGER, S
    KVAMBE, V
    MURER, F
    NORDAHL, E
    RAEDER, S
    SEIP, T
    WILSKOW, A
    YTREHUS, K
    GROTTUM, K
    LAMVIK, J
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 1988, 41 (01) : 47 - 51
12